OPK Valuation

OPKO Health Inc

Add to Watchlist

Advanced Chart

1.400

+0.04(2.941%)1D

OPK Relative Valuation

OPK's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, OPK is overvalued; if below, it's undervalued.

Historical Valuation

OPKO Health Inc (OPK) is now in the Undervalued zone, suggesting that its current forward PS ratio of 1.36 is considered Undervalued compared with the five-year average of 84.55. The fair price of OPKO Health Inc (OPK) is between 6.85 to 7.49 according to relative valuation methord. Compared to the current price of 1.41 USD , OPKO Health Inc is Undervalued By 79.4%.

Relative Value

Fair Zone

6.85-7.49

Current Price：1.41

79.4%

Undervalued

-6.90

Trailing

Forward

-15.20

EV/EBITDA

OPKO Health Inc. (OPK) has a current EV/EBITDA of -15.20. The 5-year average EV/EBITDA is -20.23. The thresholds are as follows: Strongly Undervalued below -94.19, Undervalued between -94.19 and -57.21, Fairly Valued between 16.75 and -57.21, Overvalued between 16.75 and 53.73, and Strongly Overvalued above 53.73. The current Forward EV/EBITDA of -15.20 falls within the Historic Trend Line -Fairly Valued range.

-8.10

EV/EBIT

OPKO Health Inc. (OPK) has a current EV/EBIT of -8.10. The 5-year average EV/EBIT is -0.92. The thresholds are as follows: Strongly Undervalued below -96.45, Undervalued between -96.45 and -48.68, Fairly Valued between 46.84 and -48.68, Overvalued between 46.84 and 94.60, and Strongly Overvalued above 94.60. The current Forward EV/EBIT of -8.10 falls within the Historic Trend Line -Fairly Valued range.

1.36

OPKO Health Inc. (OPK) has a current PS of 1.36. The 5-year average PS is 1.71. The thresholds are as follows: Strongly Undervalued below 0.93, Undervalued between 0.93 and 1.32, Fairly Valued between 2.10 and 1.32, Overvalued between 2.10 and 2.49, and Strongly Overvalued above 2.49. The current Forward PS of 1.36 falls within the Historic Trend Line -Fairly Valued range.

0.00

P/OCF

OPKO Health Inc. (OPK) has a current P/OCF of 0.00. The 5-year average P/OCF is 5.24. The thresholds are as follows: Strongly Undervalued below -79.44, Undervalued between -79.44 and -37.10, Fairly Valued between 47.58 and -37.10, Overvalued between 47.58 and 89.92, and Strongly Overvalued above 89.92. The current Forward P/OCF of 0.00 falls within the Historic Trend Line -Fairly Valued range.

-19.64

P/FCF

OPKO Health Inc. (OPK) has a current P/FCF of -19.64. The 5-year average P/FCF is 0.09. The thresholds are as follows: Strongly Undervalued below -111.72, Undervalued between -111.72 and -55.82, Fairly Valued between 55.99 and -55.82, Overvalued between 55.99 and 111.90, and Strongly Overvalued above 111.90. The current Forward P/FCF of -19.64 falls within the Historic Trend Line -Fairly Valued range.

OPKO Health Inc (OPK) has a current Price-to-Book (P/B) ratio of 0.80. Compared to its 3-year average P/B ratio of 0.75 , the current P/B ratio is approximately 7.25% higher. Relative to its 5-year average P/B ratio of 1.03, the current P/B ratio is about -22.47% higher. OPKO Health Inc (OPK) has a Forward Free Cash Flow (FCF) yield of approximately -0.20%. Compared to its 3-year average FCF yield of -11.91%, the current FCF yield is approximately -98.30% lower. Relative to its 5-year average FCF yield of -7.06% , the current FCF yield is about -97.12% lower.

0.80

P/B

Median3y

0.75

Median5y

1.03

-0.20

FCF Yield

Median3y

-11.91

Median5y

-7.06

Competitors Valuation Multiple

The average P/S ratio for OPK's competitors is 24.13, providing a benchmark for relative valuation. OPKO Health Inc Corp (OPK) exhibits a P/S ratio of 1.36, which is -94.36% above the industry average. Given its robust revenue growth of -12.65%, this premium appears unsustainable.

P/S

P/E

EV/EBITDA

EV/EBIT

P/S

Revenue Growth

Market Cap

US Physical Therapy Inc

Ginkgo Bioworks Holdings Inc

12.99

-11.75%

718.79M

Performance Decomposition

Market capitalization of OPK decreased by 9.09% over the past 1 year. The primary factor behind the change was an decrease in P/E Change from -5.28 to -5.49.

The secondary factor is the Margin Expansion, contributed -0.49%to the performance.

Overall, the performance of OPK in the past 1 year is driven by P/E Change. Which is more unsustainable.

-12.65%

173.63M → 151.67M

Revenue Growth

-0.49%

14.33 → 14.26

Margin Expansion

4.05%

-5.28 → -5.49

P/E Change

-9.09%